Company Filing History:
3 out of 1,929 
2 out of 1,343 
1 out of 49 Years Active: 2022-2023
Title: Nehal Gosalia: Innovator in Medical Treatments
Introduction
Nehal Gosalia is a prominent inventor based in Tarrytown, NY (US). He has made significant contributions to the field of medical treatments, particularly in addressing issues related to bone mineral density and lipid levels. With a total of 3 patents, his work has the potential to impact many lives.
Latest Patents
Gosalia's latest patents include innovative methods for treating decreased bone mineral density using zinc and ring finger 3 (ZNRF3) inhibitors. This patent outlines methods for identifying patients at risk of developing decreased bone mineral density and detecting human ZNRF3 variant nucleic acid molecules and polypeptides. Another notable patent focuses on treating increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors. This patent provides methods for identifying subjects at risk of elevated lipid levels and detecting human SREBF1 variant nucleic acid molecules and polypeptides.
Career Highlights
Throughout his career, Nehal Gosalia has worked with esteemed organizations such as the University System of Maryland and Regeneron Pharmaceuticals, Inc. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.
Collaborations
Some of his notable coworkers include Da-Wei Gong and James A Perry. Their collaborative efforts have contributed to the advancement of medical treatments and innovations in their respective fields.
Conclusion
Nehal Gosalia's work exemplifies the spirit of innovation in the medical field. His patents and collaborations highlight his commitment to improving health outcomes through scientific research and development.